| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
|
|---|---|---|---|---|
| Total Revenue
|
1,398,713 | 1,055,788 | 749,011 | 504,874 |
|
Cost of Revenue
|
-260,415 | -185,527 | -87,514 | -44,500 |
|
Gross Profit
|
1,138,298 | 870,261 | 661,497 | 460,374 |
| Selling, General and Administrative Expenses
|
-966,309 | -1,131,018 | -787,810 | -369,056 |
|
Research and Development Expenses
|
-741,343 | -1,029,700 | -751,120 | -164,774 |
|
Operating Income/Expenses
|
-1,707,652 | -2,160,718 | -1,538,930 | -533,830 |
|
Total Operating Profit/Loss
|
-569,354 | -1,290,457 | -877,433 | -73,456 |
| Total Net Finance Income/Expense
|
62,199 | 62,199 | 63,701 | 19,853 |
| Net Investment Income
|
-797 | -797 | 23,766 | 0 |
|
Other Income/Expense, Non-Operating
|
-19,569 | 3,413 | -3,105 | 999,522 |
|
Non-Operating Income/Expenses, Total
|
41,833 | 64,815 | 84,362 | 1,019,375 |
|
Pretax Income
|
-527,521 | -1,225,642 | -793,071 | 945,919 |
|
Provision for Income Tax
|
-34,937 | -24,821 | 60,951 | -208,078 |
|
Net Income from Continuing Operations
|
-562,458 | -1,250,463 | -732,120 | 737,841 |
|
Other Net of Taxes Adjustments
|
0 | 0 | 0 | -451,982 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-562,458 | -1,250,463 | -732,120 | 285,859 |
|
Net Income after Non-Controlling/Minority Interests
|
-562,458 | -1,250,463 | -732,120 | 285,859 |
|
Other Adjustments to Net Income Available to Common Stockholders
|
34 | -- | -663,068 | -- |
|
Net Income Available to Common Stockholders
|
-562,458 | -1,250,463 | -732,120 | 285,859 |
|
Dilution to Earnings
|
0 | 0 | 0 | 18,274 |
|
Diluted Net Income Available to Common Stockholders
|
-562,458 | -1,250,463 | -732,120 | 304,133 |
| Basic EPS
|
-1.08 | -3.71 | -3.11 | 0.60 |
| Diluted EPS
|
-1.08 | -3.71 | -3.11 | 0.60 |
|
Basic Weighted Average Shares Outstanding
|
524,131.50 | 337,044 | 448,206 | 474,811 |
|
Diluted Weighted Average Shares Outstanding
|
524,131.50 | 337,044 | 448,206 | 474,811 |
|
Reported Normalized Basic EPS
|
0.38 | 0.32 | 0.26 | -- |
|
Reported Normalized Diluted EPS
|
0.36 | 0.30 | 0.25 | -- |
| Income Statement, Supplemental
|
||||
|
EBIT
|
-527,521 | -1,287,841 | -856,772 | 926,066 |
|
EBITDA
|
-505,696 | -1,272,247 | -849,081 | 934,563 |
12/31/2023 - 7/31/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade